Vera Therapeutics (VERA) Financials: Revenue & Earnings
$2.21B
Market Cap
-4.78
P/E
12.63
Forward P/E
68
Score
VERA price $30.66 +0.67 +2.23%
Stocklytics score rationale: value 58, quality 45, growth 100.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A…
VERA fair value $95.12. Price $30.66. Price is 68% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -1.61 | — | 3.90M |
| 2026-08-10 | -1.52 | -1.58 | — | 1.28M |
| 2026-05-07 | -1.69 | -1.33 | — | 426.03K |
| 2026-02-26 | -1.39 | -1.34 | — | — |
| 2025-11-05 | -1.26 | -1.20 | — | — |
| 2025-08-05 | -1.20 | -0.82 | — | — |
| 2025-05-06 | -0.81 | -0.75 | — | — |
| 2025-02-26 | -0.72 | -0.83 | — | — |
| 2024-11-07 | -0.85 | -0.69 | — | — |
| 2024-08-08 | -0.62 | -0.58 | — | — |
| 2024-05-09 | -0.56 | -0.53 | — | — |
| 2024-03-20 | -0.58 | -0.53 | — | — |
| 2023-11-09 | -0.45 | -0.50 | — | — |
| 2023-08-10 | -0.46 | -0.69 | — | — |
| 2023-05-11 | -0.80 | -0.60 | — | — |
| 2023-03-28 | -1.19 | -0.93 | — | — |
| 2022-11-09 | -0.91 | -0.72 | — | — |
| 2022-08-10 | -0.55 | -0.72 | — | — |
| 2022-05-16 | -0.71 | -0.67 | — | — |
| 2022-03-24 | -0.79 | -0.49 | — | — |
| 2021-11-10 | -0.36 | -0.60 | — | — |
| 2021-08-16 | -0.33 | -0.39 | — | — |
| 2021-06-24 | -12.23 | -1.94 | — | — |
| 2021-04-23 | -2.09 | — | — | — |
| 2020-09-30 | -1.09 | — | — | — |
| 2020-06-30 | -0.88 | — | — | — |
| 2020-03-31 | -0.61 | — | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | Sell | 18.50K | $2.90 | 53.59K |
| 2026-09-15 | Fordyce Marshall | Buy | 18.50K | $2.90 | 53.59K |
| 2026-09-15 | Fordyce Marshall | Sell | 18.50K | $37.00 | 684.50K |
| 2026-09-11 | Young Joseph R | Buy | 5.00K | $3.94 | 19.70K |
| 2026-09-11 | Young Joseph R | Sell | 5.00K | $3.94 | 19.70K |
| 2026-09-02 | Fordyce Marshall | Sell | 18.50K | $2.90 | 53.59K |
| 2026-09-02 | Fordyce Marshall | Buy | 18.50K | $2.90 | 53.59K |
| 2026-09-02 | Fordyce Marshall | Sell | 18.50K | $35.12 | 649.64K |
| 2026-08-03 | Boman Nancy Lee | Buy | 63.01K | $32.23 | 2.03M |
| 2026-08-03 | Boman Nancy Lee | Buy | 44.99K | — | — |
| 2026-08-03 | Boman Nancy Lee | Other | 0 | — | — |
| 2026-07-07 | Fordyce Marshall | Sell | 46.25K | $2.90 | 133.98K |
| 2026-07-07 | Fordyce Marshall | Buy | 46.25K | $2.90 | 133.98K |
| 2026-07-07 | Fordyce Marshall | Sell | 1.00K | $40.78 | 40.78K |
| 2026-07-07 | Fordyce Marshall | Sell | 32.55K | $42.07 | 1.37M |
| 2026-07-07 | Fordyce Marshall | Sell | 10.50K | $42.86 | 450.01K |
| 2026-07-07 | Fordyce Marshall | Sell | 2.20K | $43.59 | 95.91K |
| 2026-07-07 | Fordyce Marshall | Sell | 1.00K | $40.78 | 40.78K |
| 2026-07-07 | Fordyce Marshall | Sell | 32.55K | $42.07 | 1.37M |
| 2026-07-07 | Fordyce Marshall | Sell | 10.50K | $42.86 | 450.01K |
| 2026-07-07 | Fordyce Marshall | Sell | 2.20K | $43.59 | 95.91K |
| 2026-06-23 | Fordyce Marshall | Sell | 18.50K | $2.90 | 53.59K |
| 2026-06-23 | Fordyce Marshall | Buy | 18.50K | $2.90 | 53.59K |
| 2026-06-23 | Fordyce Marshall | Sell | 18.41K | $37.93 | 698.39K |
| 2026-06-23 | Fordyce Marshall | Sell | 88 | $38.43 | 3.38K |
| 2026-06-23 | Fordyce Marshall | Sell | 18.41K | $37.93 | 698.39K |
| 2026-06-23 | Fordyce Marshall | Sell | 88 | $38.43 | 3.38K |
| 2026-05-21 | Morrison Scott W | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | Cheng Andrew | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | SEIDENBERG BETH C | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | Oliger Christy J. | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | Meyers James R | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | Hall Kimball | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | MORRISSEY MICHAEL | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-21 | ENRIGHT PATRICK G | Buy | 17.08K | $34.35 | 586.84K |
| 2026-05-12 | Fordyce Marshall | Sell | 18.50K | $2.90 | 53.59K |
| 2026-05-12 | Fordyce Marshall | Buy | 18.50K | $2.90 | 53.59K |
| 2026-05-12 | Fordyce Marshall | Sell | 14.22K | $36.64 | 520.98K |
| 2026-05-12 | Fordyce Marshall | Sell | 4.28K | $37.09 | 158.77K |
| 2026-05-12 | Fordyce Marshall | Sell | 14.22K | $36.64 | 520.98K |
| 2026-05-12 | Fordyce Marshall | Sell | 4.28K | $37.09 | 158.77K |
| 2026-04-14 | Fordyce Marshall | Sell | 14.13K | $43.66 | 616.99K |
| 2026-04-14 | Fordyce Marshall | Sell | 7.92K | $44.58 | 353.11K |
| 2026-04-14 | Fordyce Marshall | Sell | 900 | $45.51 | 40.96K |
| 2026-03-23 | Wright-Mitchell Jane | Buy | 56.85K | $40.73 | 2.32M |
| 2026-03-23 | Wright-Mitchell Jane | Buy | 42.40K | — | — |
| 2026-03-23 | Wright-Mitchell Jane | Other | 0 | — | — |
| 2026-03-13 | Young Joseph R | Buy | 10.00K | $3.94 | 39.40K |
| 2026-03-13 | Young Joseph R | Sell | 10.00K | $3.94 | 39.40K |
| 2026-03-05 | Hite Christopher | Buy | 24.94K | $38.85 | 968.80K |
| 2026-03-05 | Hite Christopher | Other | 0 | — | — |
| 2026-02-23 | Brenner Robert | Sell | 2.15K | $41.98 | 90.31K |
| 2026-02-23 | Young Joseph R | Sell | 3.12K | $41.98 | 130.86K |
| 2026-02-23 | Grant Sean | Sell | 4.95K | $41.98 | 207.78K |
| 2026-02-23 | Fordyce Marshall | Sell | 16.93K | $41.98 | 710.58K |
| 2026-02-23 | JOHNSON DAVID LEE | Sell | 2.58K | $41.98 | 108.28K |
| 2026-02-23 | Turner William D. | Sell | 2.19K | $41.98 | 91.82K |
| 2026-02-23 | Skelton Laurence Matthew | Sell | 1.58K | $41.98 | 66.42K |
| 2026-02-04 | Young Joseph R | Buy | 10.00K | — | — |
| 2026-02-04 | Young Joseph R | Buy | 20.00K | $42.74 | 854.80K |
| 2026-02-04 | Fordyce Marshall | Buy | 68.80K | — | — |
| 2026-02-04 | Fordyce Marshall | Buy | 137.50K | $42.74 | 5.88M |
| 2026-02-04 | Grant Sean | Buy | 25.00K | — | — |
| 2026-02-04 | Grant Sean | Buy | 50.00K | $42.74 | 2.14M |
| 2026-02-04 | Skelton Laurence Matthew | Buy | 20.00K | — | — |
| 2026-02-04 | Skelton Laurence Matthew | Buy | 40.00K | $42.74 | 1.71M |
| 2026-02-04 | Turner William D. | Buy | 50.00K | $42.74 | 2.14M |
| 2026-02-04 | Turner William D. | Buy | 25.00K | — | — |
| 2026-02-04 | JOHNSON DAVID LEE | Buy | 20.00K | — | — |
| 2026-02-04 | JOHNSON DAVID LEE | Buy | 40.00K | $42.74 | 1.71M |
| 2026-02-04 | Brenner Robert | Buy | 25.00K | — | — |
| 2026-02-04 | Brenner Robert | Buy | 50.00K | $42.74 | 2.14M |
| 2026-01-20 | Skelton Laurence Matthew | Other | 0 | — | — |
| 2026-01-20 | Skelton Laurence Matthew | Other | 0 | — | — |
| 2026-01-20 | Skelton Laurence Matthew | Other | 31.50K | $29.18 | 919.17K |
| 2026-01-20 | Skelton Laurence Matthew | Other | 60.00K | $41.75 | 2.50M |
| 2025-12-15 | Turner William D. | Sell | 10.00K | $15.53 | 155.30K |
| 2025-12-15 | Turner William D. | Buy | 10.00K | $15.53 | 155.30K |
| 2025-12-15 | Turner William D. | Sell | 10.00K | $50.08 | 500.77K |
| 2025-12-11 | ENRIGHT PATRICK G | Buy | 5.88K | $42.50 | 249.99K |
| 2025-12-08 | Turner William D. | Sell | 10.00K | $15.53 | 155.30K |
| 2025-12-08 | Turner William D. | Buy | 10.00K | $15.53 | 155.30K |
| 2025-12-08 | Turner William D. | Sell | 10.00K | $45.31 | 453.05K |
| 2025-12-03 | Turner William D. | Sell | 10.00K | $15.53 | 155.30K |
| 2025-12-03 | Turner William D. | Buy | 10.00K | $15.53 | 155.30K |
| 2025-12-03 | Turner William D. | Sell | 10.00K | $40.00 | 400.00K |
| 2025-11-25 | Meyers James R | Buy | 25.00K | $29.43 | 735.75K |
| 2025-11-25 | Meyers James R | Other | 0 | — | — |
| 2025-11-21 | Carter Jason S | Sell | 3.86K | $27.82 | 107.50K |
| 2025-11-13 | Young Joseph R | Buy | 10.00K | $3.94 | 39.40K |
| 2025-11-13 | Young Joseph R | Sell | 10.00K | $3.94 | 39.40K |
| 2025-11-11 | Young Joseph R | Sell | 15.00K | $29.06 | 435.87K |
| 2025-06-24 | ENRIGHT PATRICK G | Buy | 27.07K | $22.35 | 605.08K |
| 2025-06-24 | ENRIGHT PATRICK G | Buy | 13.54K | $22.35 | 302.55K |
| 2025-06-23 | ENRIGHT PATRICK G | Buy | 139.59K | $20.87 | 2.91M |
| 2025-06-23 | ENRIGHT PATRICK G | Buy | 69.80K | $20.87 | 1.46M |
| 2025-05-14 | Katabi Maha | Buy | 14.00K | $21.19 | 296.66K |
| 2025-05-14 | ENRIGHT PATRICK G | Buy | 14.00K | $21.19 | 296.66K |
| 2025-05-14 | Oliger Christy J. | Buy | 14.00K | $21.19 | 296.66K |
| 2025-05-14 | MORRISSEY MICHAEL | Buy | 14.00K | $21.19 | 296.66K |
Latest filed quarter: Q2 2026.
Institutions holding: 234, holders -4 vs prior quarter. Ownership 109.25%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 5.75M | 659.66K | +12.96% | 246.64M |
| AVORO CAPITAL ADVISORS LLC | 5.72M | -165.00K | -2.80% | 245.61M |
| STATE STREET CORP | 4.15M | 785.15K | +23.34% | 178.02M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.01M | -561.09K | -12.27% | 172.20M |
| DEEP TRACK CAPITAL, LP | 4.00M | -106.07K | -2.58% | 171.64M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.92M | 194.30K | +5.22% | 168.05M |
| KYNAM CAPITAL MANAGEMENT, LP | 2.89M | -508.17K | -14.95% | 124.01M |
| MORGAN STANLEY | 2.80M | 2.43M | +659.15% | 120.12M |
| SOFINNOVA INVESTMENTS, INC. | 2.79M | 0 | 0.00% | 119.89M |
| FMR LLC | 2.77M | 97.65K | +3.65% | 119.04M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.76M | 71.81K | +2.68% | 118.23M |
| EVERSEPT PARTNERS, LP | 2.21M | 39.48K | +1.82% | 94.95M |
| LOGOS GLOBAL MANAGEMENT LP | 2.20M | 2.20M | New | 94.40M |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.75M | 150.00K | +9.38% | 75.09M |
| BELLEVUE GROUP AG | 1.71M | 37 | +0.00% | 73.41M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.69M | 122.36K | +7.79% | 72.64M |
| ALLIANCEBERNSTEIN L.P. | 1.59M | 276.80K | +21.06% | 64.01M |
| GOLDMAN SACHS GROUP INC | 1.38M | 246.87K | +21.77% | 59.25M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.30M | 743.91K | +134.89% | 55.59M |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.25M | 197.83K | +18.81% | 53.63M |
| DEUTSCHE BANK AG\ | 1.10M | 569.64K | +106.98% | 47.29M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.08M | 541.38K | +99.92% | 46.48M |
| WOODLINE PARTNERS LP | 1.00M | 0 | 0.00% | 42.95M |
| AMERICAN CENTURY COMPANIES INC | 866.24K | 137.91K | +18.94% | 37.17M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 642.87K | 89.90K | +16.26% | 27.59M |
Vera Therapeutics, Inc. (VERA) trades at $30.66, with a market cap of $2.21B and a trailing P/E of -4.78. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insights · Dividends · Forecast · Financials · Learn
$2.21B
Market Cap
-4.78
P/E
12.63
Forward P/E
68
Score